These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
1,488 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
Baker's Authority recalled 197 units of Everything Bagel Mix on August 12, 2025. The product fails to list sesame, a major food allergen, on its label. Consumers should avoid consumption and seek refunds.
Max Mobility recalled 25,389 Smart Drive MX2+ SpeedControl Dials on August 12, 2025. A faulty electrical connection can lead to loss of control, posing injury risks. Users must stop using the device immediately and follow recall instructions.
H & N Group recalled 17,214 cases of frozen shrimp on August 12, 2025. The product may be contaminated with Cesium-137 due to unsanitary manufacturing conditions. Consumers should not consume the shrimp and seek refunds immediately.
Baker's Authority recalled 78 units of Three Seed Mix on August 12, 2025. The product lacks proper labeling for sesame, a major allergen. Consumers should not consume this product and seek a refund.
Viona Pharmaceuticals recalled 3,960 bottles of Tavaborole Topical Solution on August 12, 2025. The product may show discoloration, posing health risks to consumers. This recall affects topical solutions distributed nationwide in the USA.
Domino Foods, Inc. recalled 4,500 bags of granulated sugar on August 12, 2025. The recall stems from potential contamination with foreign objects. The affected products were distributed in California and Utah.
Wegmans Food Markets recalled 4,884 units of Grilling Camembert on August 12, 2025, due to possible contamination with Listeria monocytogenes. The affected products are packaged in black and gold metal trays and distributed in several states including New York and Pennsylvania. Consumers should not consume this product and seek a refund or replacement.
Applied Medical Technology recalled 200 NutraGlide Nasal Feeding Tubes on August 12, 2025. The distal tips may detach under lower than expected forces, posing a risk to patients. This recall affects devices distributed in Massachusetts and Rhode Island.
Applied Medical Technology recalled 840 NutraGlide Nasal Feeding Tubes on August 12, 2025. The tubes may have distal tips that detach unexpectedly, posing a risk to patients. Healthcare providers and patients must stop using the device immediately and follow recall instructions.
Applied Medical Technology recalled 390 NutraGlide Nasal Feeding Tubes on August 12, 2025, due to a risk of distal tips detaching. This recall affects models distributed in Massachusetts and Rhode Island. Patients and healthcare providers must stop using these devices immediately.
Applied Medical Technology recalled 1,780 NutraGlide Nasal Feeding Tubes on August 12, 2025, after reports of distal tips detaching. This recall affects tubes distributed in Massachusetts and Rhode Island. The detachment poses a high risk for patients requiring enteral nutrition.
Agilent Technologies Denmark ApS recalled 4,145 units of FLEX Monoclonal Mouse Anti-Human CD20cy on August 11, 2025. The recall stems from potential weak staining that may lead to false negative CD20 identification. Healthcare providers and patients must stop using the product immediately.
Agilent Technologies Denmark ApS recalled 65 units of its FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26 on August 11, 2025. The recall stems from potential weak staining that could lead to false negative CD20 identification. Healthcare providers and patients should stop using the product immediately.
Agilent Technologies recalled 67 units of FLEX Monoclonal Mouse Anti-Human CD20cy on August 11, 2025. The recall stems from the potential for weak staining leading to false negative results in B-cell identification. Healthcare providers must cease use immediately and follow recall instructions.
Lannett Company recalled 8,544 bottles of Lisdexamfetamine Dimesylate Capsules on August 11, 2025. The recall occurred due to a labeling mix-up where 40 mg capsules were mislabeled as 30 mg. This issue poses a high risk to consumers who may receive incorrect dosages.
Glenmark Pharmaceuticals Inc. recalled 22,656 bottles of Theophylline extended-release tablets on August 8, 2025. The recall follows reports of failed dissolution specifications that could impact medication efficacy. Consumers should stop using the product and consult healthcare providers immediately.
SUNGAL recalled 29 cases of canned Half Plum on August 8, 2025, due to cyclamate adulteration. The affected product may pose a health risk. Consumers in California, Maryland, New York, and Virginia should stop using the product immediately.
Quallent Pharmaceuticals recalled 3,591 bottles of Duloxetine Delayed-Release Capsules on August 8, 2025. The recall stems from CGMP deviations regarding an impurity exceeding safety limits. Consumers should stop using the product immediately and contact their healthcare provider.
Baxter Healthcare Corporation recalled 14,400 units of its Continu-Flo solution set on August 8, 2025. The recall follows customer reports of tubing separation that pose serious risks. Healthcare providers and patients must stop using the device immediately.
Philips Medical Systems Nederland B.V. recalled its IntelliSpace Cardiovascular Software 8.0.0.4 on August 8, 2025. The recall affects four units distributed nationwide, particularly in Georgia, North Carolina, and Texas. The software displays outdated information, posing a significant risk to patient safety.